Nanoparticle-Mediated Nose-to-Brain Drug Delivery Systems: A Promising Approach for CNS Therapeutics
International Journal of Pharmaceutical and Healthcare Innovation · 05.05.2026 · 3 (3) · 1008-1020
DOI: 10.62752/ijphi.v3i2.250 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical and Healthcare Innovation, online erschienen am 05.05.2026. Verfasst von Satish Singh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The nose-to-brain delivery of drugs by nanoparticles has developed as an attractive non-invasive drug delivery methodology in order to circumvent the constraints of traditional central nervous system (CNS) therapeutics, especially the constraining quality of the blood-brain barrier (BBB). Nasal delivery allows direct delivery of the drugs to the brain through the olfactory-trigeminal neural pathway and improves drug bioavailability and decreases systemic exposure. Combining the intranasal delivery systems with nanotechnology has several benefits, such as increased solubility of drugs, resistance to enzyme degradation, controlled drug release, and delivery to the selected parts of the brain. Nanoparticulate carriers including polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, liposomes, and nanoemulsions have been widely studied towards this effect. These systems allow an increase in the permeation of the nasal mucosa and increase the residence time, leading to an increase in the efficacy of the therapy in the treatment of neurological disorders like Alzheimer disease, Parkinson disease, epilepsy, and brain tumors. Although encouraging results have been seen in preclinical studies, various issues, such as mucociliary clearance, formulation stability, scalability, and regulatory factors are still a challenge. Recent developments on the surface modification and ligand-mediated targeting have further improved brain uptake and specificity. This review brings out the mechanisms, types of nanoparticles, formulation strategies, and recent advances in the nanoparticle-mediated nose-to-brain drug delivery systems and their potential in enhancing CNS therapeutics. In general, it is a revolutionize platform that has a great potential in future clinical application.
Zitieren
APA
Singh, S., & Trilochana, D. N. (2026). Nanoparticle-Mediated Nose-to-Brain Drug Delivery Systems: A Promising Approach for CNS Therapeutics. International Journal of Pharmaceutical and Healthcare Innovation, 3(3), 1008-1020. https://doi.org/10.62752/ijphi.v3i2.250
Vancouver
Singh S, Trilochana DN. Nanoparticle-Mediated Nose-to-Brain Drug Delivery Systems: A Promising Approach for CNS Therapeutics. International Journal of Pharmaceutical and Healthcare Innovation. 2026;3(3):1008-1020. doi:10.62752/ijphi.v3i2.250
BibTeX
@article{Singh2026,
author = {Singh, Satish and Trilochana, Dr. Nadipalli},
title = {Nanoparticle-Mediated Nose-to-Brain Drug Delivery Systems: A Promising Approach for CNS Therapeutics},
journal = {International Journal of Pharmaceutical and Healthcare Innovation},
year = {2026},
volume = {3},
number = {3},
pages = {1008--1020},
doi = {10.62752/ijphi.v3i2.250}
}
EUVIMED